These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 37942626)
1. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition. Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626 [TBL] [Abstract][Full Text] [Related]
2. Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system. Cheng Y; Sun R; He M; Zhang M; Hou X; Sun Y; Wang J; Xu J; He H; Wang H; Lan M; Zhao Y; Yang Y; Chen X; Gao F Int J Pharm; 2022 Apr; 618():121613. PubMed ID: 35217071 [TBL] [Abstract][Full Text] [Related]
3. An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Wang K; Ye H; Zhang X; Wang X; Yang B; Luo C; Zhao Z; Zhao J; Lu Q; Zhang H; Kan Q; Wang Y; He Z; Sun J Biomaterials; 2020 Oct; 257():120224. PubMed ID: 32736255 [TBL] [Abstract][Full Text] [Related]
4. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells. Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904 [TBL] [Abstract][Full Text] [Related]
5. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer. Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911 [TBL] [Abstract][Full Text] [Related]
6. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy. Hou X; Shou C; He M; Xu J; Cheng Y; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F Acta Pharm Sin B; 2020 Sep; 10(9):1741-1753. PubMed ID: 33088693 [TBL] [Abstract][Full Text] [Related]
7. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer. Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294 [TBL] [Abstract][Full Text] [Related]
8. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy. He M; Wang Y; Chen X; Zhao Y; Lou K; Wang Y; Huang L; Hou X; Xu J; Cai X; Cheng Y; Lan M; Yang Y; Gao F J Control Release; 2020 Mar; 319():1-14. PubMed ID: 31838205 [TBL] [Abstract][Full Text] [Related]
9. Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy. Cheng Y; Zou J; He M; Hou X; Wang H; Xu J; Yuan Z; Lan M; Yang Y; Chen X; Gao F J Control Release; 2024 Mar; 367():167-183. PubMed ID: 37562556 [TBL] [Abstract][Full Text] [Related]
10. Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology. Xu J; He M; Hou X; Wang Y; Shou C; Cai X; Yuan Z; Yin Y; Lan M; Lou K; Zhao Y; Yang Y; Chen X; Gao F Mol Pharm; 2020 Jan; 17(1):301-315. PubMed ID: 31765570 [TBL] [Abstract][Full Text] [Related]
11. The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer. Zhang W; Xia L; Ren X; Cui M; Liu T; Ling C; Xu Y; Deng D; Zhang X; Gu Y; Wang P Biomater Sci; 2020 Nov; 8(21):5941-5954. PubMed ID: 32966407 [TBL] [Abstract][Full Text] [Related]
12. Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy. He M; Sun Y; Cheng Y; Wang J; Zhang M; Sun R; Hou X; Xu J; He H; Wang H; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F J Control Release; 2023 Mar; 355():538-551. PubMed ID: 36063962 [TBL] [Abstract][Full Text] [Related]
13. An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis. Meng X; Wang M; Zhang K; Sui D; Chen M; Xu Z; Guo T; Liu X; Deng Y; Song Y AAPS PharmSciTech; 2022 Oct; 23(8):285. PubMed ID: 36258152 [TBL] [Abstract][Full Text] [Related]
14. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer. Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609 [TBL] [Abstract][Full Text] [Related]
15. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis. Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912 [TBL] [Abstract][Full Text] [Related]
16. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy. Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442 [TBL] [Abstract][Full Text] [Related]
17. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy. Fan Y; Wang Q; Lin G; Shi Y; Gu Z; Ding T Acta Biomater; 2017 Oct; 62():257-272. PubMed ID: 28859899 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy. Satsangi A; Roy SS; Satsangi RK; Tolcher AW; Vadlamudi RK; Goins B; Ong JL Biomaterials; 2015 Aug; 59():88-101. PubMed ID: 25956854 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment. Salmaso S; Mastrotto F; Roverso M; Gandin V; De Martin S; Gabbia D; De Franco M; Vaccarin C; Verona M; Chilin A; Caliceti P; Bogialli S; Marzaro G J Control Release; 2021 Dec; 340():318-330. PubMed ID: 34748872 [TBL] [Abstract][Full Text] [Related]
20. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]